Endostatin and angiostatin: the next anti-angiogenesis generation

O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996; 2, 689-692. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88, 277-285. Folkman J. Angiogenesis and angiogenesis inhibition: an overview. EXS 1997; 79, 1-8. Folkman J. Angiogenesis inhibitors generated by tumors. Mol Med 1995; 1, 120-122. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390, 404-407. Folkman J, Hochberg M, Knighton D. Self-regulation of growth in three dimensions: the role of surface area limitations. In: Clarkson, B Baserga R (eds), Control of Proliferation in Animal Cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1974: 833-842. Folkman J. Fighting cancer by attacking its blood supply. Sci Am 1996; 150-154. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55, 1856-1862. Liotta LA, Steeg PS. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 1991; 64, 327. Liotta LA, Kleinerman J, Saidel G. Quantitative relationships of intravascular tumor cells: tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974; 34, 997-1003.